PREVALENCE OF SLEEP DISORDERED BREATHING IN PATIENTS WITH NEWLY DIAGNOSED ACROMEGALY

Cover Page


Cite item

Full Text

Abstract

Background: Obstructive sleep disordered breathing or obstructive sleep apnea (OSA) is the most common respiratory impairment in acromegaly. OSA is bound up with heightened cardiovascular mortality. Aim: Тo study frequency, features, and structure of sleep disordered breathing in patients with newly diagnosed acromegaly and to elucidate the factors influencing their development. Materials and methods: 38 patients (10 men, 28 women, median age 53 (28-76) years, median body mass index (BMI) 29 (19.9-44.3) kg/m²) with newly diagnosed acromegaly were recruited into the study. All subjects underwent full polysomnography (Embla N7000, Natus, USA) and Remlogica software (USA). Results: Sleep disordered breathing was found in 28 (73.7%) patients. OSA was revealed in all cases, in 11 (39.3%) subjects it was mixed. In 10 (35.7%) patients OSA was mild, in 8 (28.6%) moderate, and in 10 (35.7%) severe. BMI (р<0.01), disease duration (р=0.003), and insulin-like growth factor-1 (IGF-1) level (р=0.04) were different in patients without OSA and patients with moderate-to-severe OSA. No difference was found in sex (р=0.4), age (р=0.064), and growth hormone level (р=0.6). Frequency of arterial hypertension, diabetes mellitus, and other glucose metabolism impairments was the same in subjects without OSA and with severe-to-moderate OSA. Conclusion: All patients with newly diagnosed acromegaly should undergo polysomnography. BMI, disease duration, and IGF-1 level are significant risk factors for OSA development. Correlation OSA with arterial hypertension and glucose metabolism impairments needs to be further investigated.

About the authors

U. A. Tsoy

Almazov Federal Medical Research Centre (Almazov FMRC); 2 Akkuratova ul., Saint Petersburg, 197341, Russian Federation

Author for correspondence.
Email: utsoi@mail.ru
MD, PhD, leading researcher of the Institute of Endocrinology, Almazov FMRC Россия

L. S. Korostovtseva

Almazov Federal Medical Research Centre (Almazov FMRC); 2 Akkuratova ul., Saint Petersburg, 197341, Russian Federation

Email: fake@neicon.ru
MD, PhD, researcher of the Laboratory of Pathogenesis and Therapy of Arterial Hypertension, Almazov FMRC Россия

Yu. V. Sviryaev

Almazov Federal Medical Research Centre (Almazov FMRC); 2 Akkuratova ul., Saint Petersburg, 197341, Russian Federation

Email: fake@neicon.ru
MD, PhD, senior researcher of the Laboratory of Pathogenesis and Therapy of Arterial Hypertension, Almazov FMRC Россия

A. P. Semenov

Almazov Federal Medical Research Centre (Almazov FMRC); 2 Akkuratova ul., Saint Petersburg, 197341, Russian Federation

Email: fake@neicon.ru

Physician of the Cardiologic Department No.2, junior researcher of the Laboratory of Pathogenesis and Therapy of Arterial Hypertension, Almazov FMRC

Россия

D. A. Vaulina

First Pavlov State Medical University of St. Petersburg (Pavlov FSPSMU); 6-8 L’va Tolstogo ul., Saint Petersburg, 197022, Russian Federation

Email: fake@neicon.ru
physician-intern, Pavlov FSPSMU Россия

S. O. Kravchenko

First Pavlov State Medical University of St. Petersburg (Pavlov FSPSMU); 6-8 L’va Tolstogo ul., Saint Petersburg, 197022, Russian Federation

Email: fake@neicon.ru

physician-intern, Pavlov FSPSMU

Россия

A. O. Konradi

Almazov Federal Medical Research Centre (Almazov FMRC); 2 Akkuratova ul., Saint Petersburg, 197341, Russian Federation

Email: fake@neicon.ru

MD, PhD, Professor, Head of the Research Department of Arterial Hypertension, Deputy Director for research work, Almazov FMRC

Россия

E. N. Grineva

Almazov Federal Medical Research Centre (Almazov FMRC); 2 Akkuratova ul., Saint Petersburg, 197341, Russian Federation

Email: fake@neicon.ru

MD, PhD, Professor, Director of the Institute of Endocrinology, Almazov
FMRC

Россия

References

  1. Ben-Shlomo A, Melmed S. Acromegaly. Endocrinol Metab Clin North Am. 2008;37(1):101-22, viii.
  2. Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355(24):2558-73.
  3. Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM. Mortality in patients with pituitary disease. Endocr Rev. 2010;31(3):301-42.
  4. Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med. 1991;115(7):527-32.
  5. Rosenow F, Reuter S, Deuss U, Szelies B, Hilgers RD, Winkelmann W, Heiss WD. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol (Oxf). 1996;45(5):563-9.
  6. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute, National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080-111.
  7. Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, Levy P, Riha R, Bassetti C, Narkiewicz K, Mancia G, Mc-Nicholas WT; European Respiratory Society; EU COST ACTION B26 members. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30(4):633-46.
  8. Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM; American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597-619.
  9. Phillips CL, O’Driscoll DM. Hypertension and obstructive sleep apnea. Nat Sci Sleep. 2013;5:43-52.
  10. Bradley TD, Floras JS. Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation. 2003;107(12):1671-8.
  11. Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O’Connor GT, Rapoport DM, Redline S, Resnick HE, Robbins JA, Shahar E, Unruh ML, Samet JM. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6(8): e1000132.
  12. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365(9464):1046-53.
  13. Sze L, Schmid C, Bloch KE, Bernays R, Brändle M. Effect of transsphenoidal surgery on sleep apnoea in acromegaly. Eur J Endocrinol. 2007;156(3):321-9.
  14. Davi’ MV, Dalle Carbonare L, Giustina A, Ferrari M, Frigo A, Lo Cascio V, Francia G. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol 2008.159(5):533-40.
  15. Fatti LM, Scacchi M, Pincelli AI, Lavezzi E, Cavagnini F. Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary. 2001;4(4):259-62.
  16. Punjabi NM. The epidemiology of adult obstructive apnea. Proc Am Thorac Soc. 2008;5(2):136-43.
  17. Berg C, Wessendorf TE, Mortsch F, Forsting M, Teschler H, Weischer T, Mann K, Saller B, Herrmann BL. Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. Eur J Endocrinol. 2009; 161(6):829-35.
  18. Dostalova S, Sonka K, Smahel Z, Weiss V, Marek J, Horinek D. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur J Endocrinol. 2001;144(5):491-7.
  19. Ip MS, Tan KC, Peh WC, Lam KS. Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin Endocrinol (Oxf). 2001;55(4):477-83.
  20. Ваулина ДА, Свиряев ЮВ, Цой УА, Коростовцева ЛС, Семенов АП, Непран ВИ, Кравченко СО, Конради АО. Синдром апноэ во сне при акромегалии: случайный попутчик или постоянный спутник? Бюллетень Федерального центра сердца крови и эндокринологии им. В.А. Алмазова. 2013;(4):99-105. (Vaulina DA, Sviryaev YuV, Tsoy UA, Korostovtseva LS, Semenov AP, Nepran VI, Kravchenko SO, Konradi AO. [Sleep apnea syndrome in acromegaly: a satellite by chance or a causal relation?]. Byulleten’ Federal’nogo tsentra serdtsa krovi i endokrinologii im. V.A. Almazova. 2013;(4):99-105. Russian).
  21. Grunstein RR, Ho KK, Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med. 1994;121(7):478-83.
  22. Van Haute FR, Taboada GF, Corrêa LL, Lima GA, Fontes R, Riello AP, Dominici M, Gadelha MR. Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis ofcephalometric parameters by magnetic resonance imaging. Eur J Endocrinol. 2008;158(4):459-65.
  23. Vannucci L, Luciani P, Gagliardi E, Paiano S, Duranti R, Forti G, Peri A. Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. J Endocrinol Invest. 2013;36(4):237-42.
  24. Hernández-Gordillo D, Ortega-Gómez Mdel R, Galicia-Polo L, Castorena-Maldonado A, Vergara-López A, Guillén-González MÁ, Torre-Bouscoulet L. Sleep apnea in patients with acromegaly. Frequency, characterization and positive pressure titration. Open Respir Med J. 2012;6:28-33.
  25. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A, Kales A. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000;160(15):2289-95.
  26. Rajagopalan N. Obstructive sleep apnea: not just a sleep disorder. J Postgrad Med. 2011;57(2):168-75.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Tsoy U.A., Korostovtseva L.S., Sviryaev Y.V., Semenov A.P., Vaulina D.A., Kravchenko S.O., Konradi A.O., Grineva E.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies